Skip to content
zameds

Human protein c (Ceprotin)

Human protein c

Takeda (Pty) Ltd

Every registration of this product has been cancelled.

S4

Registration

Applicant
Takeda (Pty) Ltd
Registrations
2
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Ceprotin 500 IU

EACH VIAL CONTAINS HUMAN PROTEIN C 500,0 IU

500 IUA390417A39/30.4/0417CancelledS4None
Ceprotin 1000 IU

EACH VIAL CONTAINS HUMAN PROTEIN C 1000,0 iu

1000 IUA390418A39/30.4/0418CancelledS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence medium.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Human protein c

  • S4: Protein c

    Consolidated Schedules 06 July 2026, line 7673

Pharmacological class: Probiotics. (class 30.4)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

This product's active ingredient could not be matched to a single known compound.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles